Palonosetron Labatec 0.25 mg/ 5 ml, solution injectable i.v.

7680684980015 CH-68498 Lösung
Palonosetron Labatec 0.25 mg/ 5 ml, solution injectable i.v.
Palonosetron Labatec 0.25 mg/ 5 ml, solution injectable i.v.
Palonosetron Labatec 0.25 mg/ 5 ml, solution injectable i.v.
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
28/07/2023
Summary of Product Characteristics
Français
28/07/2023
Summary of Product Characteristics
Italien
28/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
0.25 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Reimbursement information

Public price
CHF 60.75
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2022

Authorization holder

Labatec Pharma SA

1217 Meyrin

Authorization information

Swissmedic authorization number
68498
Drug name
Palonosetron Labatec 0.25 mg/ 5 ml, solution injectable i.v.
Galenic form
LSINJ
ATC Code
A04AA05
Authorization status
Z
Dispensing category
B
First authorization
18/05/2022
Authorization expiration date
17/05/2027
IT Number
01.09.0.
Domain
Human medicine

Package details

Description (FR)
PALONOSETRON Labatec sol inj 0.25 mg/5ml 5 ml
Description (DE)
PALONOSETRON Labatec Inj Lös 0.25 mg/5ml 5 ml
Market launch
18/05/2022
Narcotic (BTM)
No

Original drug

Aloxi, Injektionslösung
GTIN: 7680570420014
CHF 68.15
View original